105 related articles for article (PubMed ID: 19212144)
1. Temsirolimus-induced glomerulopathy.
Izzedine H; Boostandoot E; Spano JP; Bardier A; Khayat D
Oncology; 2009; 76(3):170-2. PubMed ID: 19212144
[TBL] [Abstract][Full Text] [Related]
2. Temsirolimus (Torisel) for advanced renal cell carcinoma.
Med Lett Drugs Ther; 2007 Dec; 49(1276):103-4. PubMed ID: 18084154
[No Abstract] [Full Text] [Related]
3. Experiences and practical conclusions concerning temsirolimus use and adverse event management in advanced renal cell carcinoma within a compassionate use program in Germany.
Gerullis H; Bergmann L; Maute L; Eimer C; Otto T
Cancer Chemother Pharmacol; 2009 May; 63(6):1097-102. PubMed ID: 18818922
[TBL] [Abstract][Full Text] [Related]
4. [Acute renal failure in a patient with renal carcinoma treated with temsirolimus].
Heras M; Fernández-Reyes MJ; Rodríguez A; Molina A; Esteban B; Alvarez-Ude F
Nefrologia; 2009; 29(6):612. PubMed ID: 19936012
[No Abstract] [Full Text] [Related]
5. Temsirolimus in renal cell carcinoma.
Otto T; Eimer C; Gerullis H
Transplant Proc; 2008 Dec; 40(10 Suppl):S36-9. PubMed ID: 19100905
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous and mucosal aphthosis during temsirolimus therapy for advanced renal cell carcinoma: review of cutaneous and mucosal side effects of mTOR inhibitors.
De Masson A; Fouchard N; Méry-Bossard L; Dauendorffer JN
Dermatology; 2011; 223(1):4-8. PubMed ID: 21846963
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant temsirolimus effectiveness in downstaging advanced non-clear cell renal cell carcinoma.
Rodríguez Faba O; Breda A; Rosales A; Palou J; Algaba F; Maroto Rey P; Villavicencio H
Eur Urol; 2010 Aug; 58(2):307-10. PubMed ID: 20347211
[TBL] [Abstract][Full Text] [Related]
8. Prolonged response to temsirolimus in a pre-treated patient with metastatic renal cell carcinoma and poor performance status.
Jafri M; Douis H; Porfiri E
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):657-8. PubMed ID: 18644704
[No Abstract] [Full Text] [Related]
9. Temsirolimus in patients with advanced renal cell carcinoma: an overview.
Bhatia S; Thompson JA
Adv Ther; 2009 Jan; 26(1):55-67. PubMed ID: 19172239
[TBL] [Abstract][Full Text] [Related]
10. Comparison of temsirolimus pharmacokinetics in patients with renal cell carcinoma not receiving dialysis and those receiving hemodialysis: a case series.
Lunardi G; Armirotti A; Nicodemo M; Cavallini L; Damonte G; Vannozzi MO; Venturini M
Clin Ther; 2009 Aug; 31(8):1812-9. PubMed ID: 19808140
[TBL] [Abstract][Full Text] [Related]
11. Tumour flare during interruption of temsirolimus treatment for metastatic renal cell cancer.
Paterson C; Jones RJ
Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):732-3. PubMed ID: 19665360
[No Abstract] [Full Text] [Related]
12. [Adverse events associated with temsirolimus for patients with metastatic renal cell carcinoma].
Miyake H; Fujisawa M
Hinyokika Kiyo; 2012 Nov; 58(11):651-4. PubMed ID: 23254795
[TBL] [Abstract][Full Text] [Related]
13. Lingual angioedema associated with everolimus.
Mackenzie M; Wood LA
Acta Oncol; 2010; 49(1):107-9. PubMed ID: 20100146
[No Abstract] [Full Text] [Related]
14. Temsirolimus for advanced renal-cell carcinoma.
Ferretti G
N Engl J Med; 2007 Sep; 357(10):1050; author reply 1050-1. PubMed ID: 17823993
[No Abstract] [Full Text] [Related]
15. Post-transplantation proteinuria and sirolimus.
Izzedine H; Brocheriou I; Frances C
N Engl J Med; 2005 Nov; 353(19):2088-9. PubMed ID: 16282189
[No Abstract] [Full Text] [Related]
16. Temsirolimus for advanced renal cell carcinoma.
Figlin RA
Clin Adv Hematol Oncol; 2007 Nov; 5(11):893. PubMed ID: 18185488
[No Abstract] [Full Text] [Related]
17. Eosinophilic rash secondary to temsirolimus.
Gandhi M; Kuzel T; Lacouture M
Clin Genitourin Cancer; 2009 Aug; 7(2):E34-6. PubMed ID: 19692320
[TBL] [Abstract][Full Text] [Related]
18. Late conversion to everolimus complicated with necrotizing glomerulonephritis in a renal allograft recipient: case report.
Nowacka-Cieciura E; Perkowska-Ptasińska A; Sulikowska-Rowińska A; Cieciura T; Wazna E; Durlik M
Transplant Proc; 2009; 41(1):441-5. PubMed ID: 19249576
[TBL] [Abstract][Full Text] [Related]
19. Temsirolimus in metastatic renal cell carcinoma.
Négrier S
Ann Oncol; 2008 Aug; 19(8):1369-1370. PubMed ID: 18504249
[No Abstract] [Full Text] [Related]
20. Everolimus- and temsirolimus-associated enteritis: report of three cases.
Parithivel K; Ramaiya N; Jagannathan JP; O'Regan K; Krajewski K; Fisher D; Choueiri TK; Jacobsen E
J Clin Oncol; 2011 May; 29(14):e404-6. PubMed ID: 21357780
[No Abstract] [Full Text] [Related]
[Next] [New Search]
